Illness	Number of cases
Malignant neoplasm of prostate (C61)	124
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	122
Hyperplasia of prostate (N40)	102
Calculus of kidney and ureter - Calculus of ureter (N20.1)	98
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	83
Calculus of kidney and ureter - Calculus of kidney (N20.0)	75
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	69
Cystitis (N30.2)	60
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	55
Unspecified haematuria (R31)	55

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	615
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	403
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	343
Insertion, exchange or removal of a ureteral stent (8-137.00)	327
Insertion, exchange or removal of a ureteral stent (8-137.10)	321
Computed tomography of the abdomen with contrast medium (3-225)	287
(8-137.20)	195
Examination of the ureter by endoscopy (1-665)	185
Examination of the urethra and the urinary bladder by endoscopy (1-661)	150
Operation using a surgical robot (5-987.0)	143

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ25
CQ06
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
251	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
184	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
157	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Doctoral supervision
Participation in multi-centre phase III/IV studies
Editors of scientific journals/textbooks
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences

Training

No.	Training in other healing professions	Comment
HB20	Nursing professional B. Sc.
HB17	Auxiliary nurse (m/f)
HB03	Physical therapist / physiotherapist (m/f)
HB06	Occupational therapist (m/f)
HB07	Surgical technical assistant (m/f)
HB10	Midwife (m/f)
HB19	Nursing professionals
HB15	Anaesthesia technical assistant (m/f)
HB01	Nurse and health care worker (m/f)
HB09	Speech therapist (m/f)